TokenPost topic

IGC Pharma

1 TokenPost story is tagged IGC Pharma. The newest appear first.

Latest IGC Pharma stories

• IGC Pharma Reports $0.32 Million in Third-Quarter Revenue

  Net loss attributable to common stockholders widened to $2.046 million from $1.821 million, while basic and diluted loss per share was 2 cents.

  Nov 10, 2026, 4:42 AM EST · Business